Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development (Q40597257)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2003
edit
Language Label Description Also known as
English
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development
scientific article published on January 2003

    Statements

    Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development (English)
    Avindra Nath
    Elizabeth Hall
    Marnia Tuzova
    Michael Dobbs
    Melina Jons
    Caroline Anderson
    Jerold Woodward
    Zhihong Guo
    Weiming Fu
    Richard Kryscio
    David Wekstein
    Charles Smith
    William R Markesbery
    1 January 2003
    29-39

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit